Cargando…
Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876905/ https://www.ncbi.nlm.nih.gov/pubmed/35148283 http://dx.doi.org/10.18632/aging.203888 |
_version_ | 1784658280830730240 |
---|---|
author | Tao, Haisu Zhang, Yuxin Yuan, Tong Li, Jiang Liu, Junjie Xiong, Yixiao Zhu, Jinghan Huang, Zhiyong Wang, Ping Liang, Huifang Zhang, Erlei |
author_facet | Tao, Haisu Zhang, Yuxin Yuan, Tong Li, Jiang Liu, Junjie Xiong, Yixiao Zhu, Jinghan Huang, Zhiyong Wang, Ping Liang, Huifang Zhang, Erlei |
author_sort | Tao, Haisu |
collection | PubMed |
description | Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. Results: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management. |
format | Online Article Text |
id | pubmed-8876905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-88769052022-03-01 Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma Tao, Haisu Zhang, Yuxin Yuan, Tong Li, Jiang Liu, Junjie Xiong, Yixiao Zhu, Jinghan Huang, Zhiyong Wang, Ping Liang, Huifang Zhang, Erlei Aging (Albany NY) Research Paper Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. Results: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management. Impact Journals 2022-02-11 /pmc/articles/PMC8876905/ /pubmed/35148283 http://dx.doi.org/10.18632/aging.203888 Text en Copyright: © 2022 Tao et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Tao, Haisu Zhang, Yuxin Yuan, Tong Li, Jiang Liu, Junjie Xiong, Yixiao Zhu, Jinghan Huang, Zhiyong Wang, Ping Liang, Huifang Zhang, Erlei Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title | Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title_full | Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title_fullStr | Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title_full_unstemmed | Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title_short | Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma |
title_sort | identification of an emt-related lncrna signature and linc01116 as an immune-related oncogene in hepatocellular carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876905/ https://www.ncbi.nlm.nih.gov/pubmed/35148283 http://dx.doi.org/10.18632/aging.203888 |
work_keys_str_mv | AT taohaisu identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT zhangyuxin identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT yuantong identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT lijiang identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT liujunjie identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT xiongyixiao identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT zhujinghan identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT huangzhiyong identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT wangping identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT lianghuifang identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma AT zhangerlei identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma |